Bain Capital Life Sciences Investors as of Dec. 31, 2022
Portfolio Holdings for Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors holds 33 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Springworks Therapeutics (SWTX) | 14.0 | $126M | 4.8M | 26.01 | |
| Nuvalent Inc-a (NUVL) | 11.9 | $107M | 3.6M | 29.78 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 10.1 | $91M | 8.3M | 10.90 | |
| Natera (NTRA) | 6.3 | $56M | 1.4M | 40.17 | |
| Mersana Therapeutics (MRSN) | 5.7 | $51M | 8.7M | 5.86 | |
| Arcutis Biotherapeutics (ARQT) | 5.0 | $44M | 3.0M | 14.80 | |
| Crinetics Pharmaceuticals In (CRNX) | 4.7 | $42M | 2.3M | 18.30 | |
| Dynavax Technologies Corp Com New (DVAX) | 4.7 | $42M | 3.9M | 10.64 | |
| Pharvaris N V (PHVS) | 4.0 | $36M | 3.2M | 11.25 | |
| Cara Therapeutics (CARA) | 3.2 | $29M | 2.7M | 10.74 | |
| Protagonist Therapeutics (PTGX) | 2.9 | $26M | 2.4M | 10.91 | |
| Annexon (ANNX) | 2.8 | $25M | 4.9M | 5.17 | |
| Eqrx | 2.8 | $25M | 10M | 2.46 | |
| Cti Biopharma | 2.5 | $23M | 3.8M | 6.01 | |
| Nurix Therapeutics (NRIX) | 2.2 | $20M | 1.8M | 10.98 | |
| Savara (SVRA) | 2.0 | $18M | 12M | 1.55 | |
| Solid Biosciences Com New (SLDB) | 1.9 | $17M | 3.1M | 5.38 | |
| Tango Therapeutics (TNGX) | 1.6 | $14M | 1.9M | 7.25 | |
| 2seventy Bio Common Stock (TSVT) | 1.5 | $13M | 1.4M | 9.37 | |
| X4 Pharmaceuticals (XFOR) | 1.4 | $12M | 12M | 0.99 | |
| Atea Pharmaceuticals (AVIR) | 1.3 | $12M | 2.5M | 4.81 | |
| ACADIA Pharmaceuticals (ACAD) | 1.2 | $11M | 701k | 15.92 | |
| C4 Therapeutics Com Stk (CCCC) | 1.1 | $9.7M | 1.6M | 5.90 | |
| Rapid Micro Biosystems Class A Com (RPID) | 1.1 | $9.5M | 8.4M | 1.13 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.9 | $7.6M | 2.1M | 3.59 | |
| Xilio Therapeutics (XLO) | 0.8 | $7.5M | 2.8M | 2.69 | |
| Marinus Pharmaceuticals Com New (MRNS) | 0.6 | $5.7M | 1.4M | 3.98 | |
| Third Harmonic Bio (THRD) | 0.6 | $5.0M | 1.2M | 4.30 | |
| Nautilus Biotechnology (NAUT) | 0.4 | $3.6M | 2.0M | 1.80 | |
| Adagio Therapeutics (IVVD) | 0.3 | $2.9M | 1.9M | 1.50 | |
| Aptinyx | 0.3 | $2.5M | 8.9M | 0.29 | |
| Aeglea Biotherapeutics | 0.3 | $2.4M | 5.3M | 0.45 | |
| Newamsterdam Pharma Company *w Exp 11/22/202 (NAMSW) | 0.0 | $86k | 100k | 0.86 |
